Pediapharm Inc. (CVE:PDP – Get Free Report) shot up 1.7% during mid-day trading on Thursday . The company traded as high as C$0.30 and last traded at C$0.30. Approximately 26,000 shares changed hands during mid-day trading, a decline of 74% from the average session volume of 100,369 shares. The stock had previously closed at C$0.29.
Pediapharm Stock Performance
The firm has a market cap of C$66.36 million and a price-to-earnings ratio of -4.11. The firm’s 50 day moving average is C$0.30 and its 200-day moving average is C$0.30. The company has a debt-to-equity ratio of 186.87, a quick ratio of 0.71 and a current ratio of 1.12.
Pediapharm Company Profile
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.
Read More
- Five stocks we like better than Pediapharm
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
- AirJoule Technologies: Short Squeeze Setup Amid Rising Risks
- MarketBeat Week in Review – 08/10 – 08/14
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
